December 27, 2016 / 12:12 PM / 8 months ago

BRIEF-Positive clinical results of Crescendo's Vectra Da Test

Dec 27 (Reuters) - Myriad Genetics Inc :

* Crescendo Bioscience-vectra da better than clinical inflammatory biomarkers to predict response to non-biological therapy intensification versus anti-tnf therapy

* Positive clinical utility results of Crescendo's Vectra da test for rheumatoid arthritis published in the journal arthritis & rheumatology Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below